June 20, 2025
BARCELONA, Spain — Data from a prospective imaging study question the use of x-ray radiography first in the diagnostic workup of patients with suspected axial spondyloarthritis […]
June 18, 2025
TOPLINE: While Raynaud phenomenon is often the initial clinical manifestation of systemic sclerosis (SSc), over 30% of patients in two large US cohorts presented first with […]
June 16, 2025
TOPLINE: In patients with early rheumatoid arthritis (RA), methotrexate-based strategies were associated with a lower risk for serious infections compared with strategies using other conventional synthetic […]
June 16, 2025
A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women with […]
June 14, 2025
BARCELONA, Spain — All patients with systemic sclerosis (SSc) and mixed connective tissue disease (MCTD) should be screened for interstitial lung disease (ILD), according to new […]
June 14, 2025
BARCELONA, Spain — When to use apremilast and biologics such as adalimumab and infliximab and how to deal with vascular involvement are some of the main […]
June 14, 2025
TOPLINE: Vasoactive vasodilating drugs (VVDs) have differential effects on the progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD), according to a post hoc analysis of prospectively […]
June 13, 2025
BARCELONA, Spain — The JAK inhibitor upadacitinib can effectively treat systemic sclerosis-associated interstitial lung disease (SSc-ILD), according to results from a new clinical trial. Patients treated […]
June 13, 2025
BARCELONA, Spain — Monitoring serum hydroxychloroquine levels could help to ensure that patients with systemic lupus erythematosus (SLE) are being treated with the drug optimally, according […]